Meisoindigo ydrochloride Smiles: C(NC1=NC(=NN=C1C1C=CC=CC=1)C1=CC=CC=N1)C1C=CC(=CC=1)C1C=CC=CC=1

Smiles: C(NC1=NC(=NN=C1C1C=CC=CC=1)C1=CC=CC=N1)C1C=CC(=CC=1)C1C=CC=CC=1

which is necessary for oxidative phosphorylation of ADP to ATP

the polyubiquitinated protein is degraded by proteasome

WZB117 is a prototype for further development of anticancer therapeutics targeting Glut1-mediated glucose transport and glucose metabolism

GSK690693 also results in an acute increase in blood glucose

Meisoindigo ydrochloride Smiles: C(NC1=NC(=NN=C1C1C=CC=CC=1)C1=CC=CC=N1)C1C=CC(=CC=1)C1C=CC=CC=1Meisoindigo, also known as N Methylisoindigotin and Dian III, is an apoptosis inducer and potential agent for AML. Meisoindigo has been a routine therapeutic agent in the clinical treatment of chronic myelogenous leukemia (CML) in China since the 1980s. Meisoindigo is a promising agent with in vitro and in vivo activity against human acute myeloid leukemia. Product information CAS Number: 97207 47 1 Molecular Weight: 276. 29 Formula: C17H12N2O2